Regional map of medicines
Argentina
139,000people on antiretroviral treatment (2019)
83 %treatment coverage (2019)
Mixedhealth insurance model
Antiretroviral medicines (2013, 2017, 2018)
| Medicine | Year | Unit price (US$) | Cost per person per year (US$) | Patent in force | Data protection | Monopoly | Possible savings per person per year (US$) |
|---|---|---|---|---|---|---|---|
| Abacavir 300 mg | 2013 | 1.49 | 1,090 | Yes | No | No | 919 |
| Atazanavir 300 mg | 2013 | 5.86 | 2,138 | Yes | No | Yes | 1,907 |
| Etravirina 100 mg | 2013 | 9.04 | 13,199 | Yes | No | Yes | 12,732 |
| Lopinavir Ritonavir 200mg - 50 mg | 2013 | 1.84 | 2,680 | Yes | No | Yes | 2,317 |
| Raltegravir 400 mg | 2013 | 12.1 | 8,831 | No | No | Yes | 7,079 |
| Emtricitabina Tenofovir 200mg - 300 mg | 2013 | 11.64 | 4,250 | No | No | Yes | 4,153 |
| Maraviroc 300 mg | 2013 | — | — | — | — | — | — |
| Emtricitabina-tenofovir-efavirenz 600 mg - 300 mg - 200 mg | 2013 | 8.5 | 3,103 | No | — | Yes | 2,921 |
| Abacavir/ Lamivudina 300 | 2017 | — | — | No | No | — | — |
| Abacavir/ Lamivudina 300 | 2018 | — | — | No | No | No | — |
Epidemiological data
| Year | People on treatment | People without treatment | Treatment coverage |
|---|---|---|---|
| 2013 | 50,725 | 62,000 | 81 % |
| 2019 | 139,000 | — | 83 % |
Health coverage
- Insurance model
- Mixed (subsidized and contributive)
- Provision of antiretrovirals
- Free of charge. Provided by each sub-system
- Procurement of antiretrovirals
- Decentralized in each sub-system
The data were provided by RedLAM member organizations at the time; each table shows the year.